Titelia

Holdings of Direxion Daily S&P Biotech Bull 3X Shares

Direxion Shares ETF Trust · 145 declared positions · as of Apr 30, 2026

Original filing · Net assets 518.9M $ · Ten largest lines: 14.8 % of the equity sleeve

Sector breakdown

  • Health care 11.8 %
  • Materials 1.1 %
  • Industrials 1.1 %
  • Unattributed 85.9 %

Titelia classification, company by company. The unattributed share stays visible.

Currency breakdown

  • USD 100.0 %

The quoted currency of each line, as declared.

Country breakdown

  • US 95.2 %
  • IE 1.5 %
  • CH 1.2 %
  • BM 1.1 %
  • VG 0.5 %
  • NL 0.5 %

Shares computed on the equity sleeve.

CountryLinesValueShare
US139406.1M $95.23 %
IE26.5M $1.53 %
CH15.1M $1.19 %
BM14.7M $1.10 %
VG12.1M $0.50 %
NL11.9M $0.45 %

Positions

CompanySharesValueWeight
Apellis Pharmaceuticals Inc 194,2508M $1.53 %
Revolution Medicines Inc 48,7487M $1.35 %
Travere Therapeutics Inc 164,0676.9M $1.33 %
Arrowhead Pharmaceuticals Inc 83,5586.1M $1.18 %
Twist Bioscience Corp 103,6036.1M $1.17 %
Summit Therapeutics Inc 278,8476M $1.15 %
Alkermes PLC 174,8235.9M $1.14 %
TG Therapeutics Inc 173,0805.8M $1.13 %
Madrigal Pharmaceuticals Inc 11,2495.8M $1.12 %
Beam Therapeutics Inc 186,1545.6M $1.09 %
Apogee Therapeutics Inc 65,0065.4M $1.04 %
Scholar Rock Holding Corp 112,4255.2M $1.01 %
Praxis Precision Medicines Inc 16,3455.2M $1.00 %
Exelixis Inc 116,2815.2M $1.00 %
Mirum Pharmaceuticals Inc 52,9175.1M $0.99 %
United Therapeutics Corp 8,9145.1M $0.98 %
Natera Inc 24,6965.1M $0.98 %
Celcuity Inc 41,9415.1M $0.98 %
CRISPR Therapeutics AG 97,2355.1M $0.98 %
Krystal Biotech Inc 19,0375M $0.96 %
Protagonist Therapeutics Inc 50,3215M $0.96 %
Neurocrine Biosciences Inc 37,4764.9M $0.95 %
Incyte Corp 51,2874.9M $0.94 %
CG oncology Inc 73,1704.9M $0.94 %
Cytokinetics Inc 76,2974.9M $0.94 %
Nuvalent Inc 48,5214.9M $0.94 %
Ionis Pharmaceuticals Inc 64,9114.9M $0.94 %
Bridgebio Pharma Inc 68,0034.8M $0.93 %
Vaxcyte Inc 84,3884.8M $0.93 %
Kymera Therapeutics Inc 59,5534.8M $0.93 %
Biogen Inc 25,4844.8M $0.93 %
Cogent Biosciences Inc 134,5544.8M $0.93 %
PTC Therapeutics Inc 73,9284.8M $0.93 %
Insmed Inc 34,8304.7M $0.92 %
Alnylam Pharmaceuticals Inc 15,1514.7M $0.90 %
Roivant Sciences Ltd 164,1214.7M $0.90 %
Halozyme Therapeutics Inc 73,0234.6M $0.90 %
Arcutis Biotherapeutics Inc 196,9914.6M $0.88 %
Spyre Therapeutics Inc 61,2704.6M $0.88 %
Soleno Therapeutics Inc 85,6994.5M $0.87 %
AbbVie Inc 21,3224.5M $0.87 %
Amgen Inc 12,8534.5M $0.86 %
Regeneron Pharmaceuticals, Inc. 6,2674.4M $0.85 %
Ultragenyx Pharmaceutical Inc 178,0574.4M $0.85 %
ACADIA Pharmaceuticals Inc 195,5424.4M $0.85 %
Rhythm Pharmaceuticals Inc 53,9304.4M $0.85 %
Gilead Sciences Inc 33,2554.4M $0.84 %
BioMarin Pharmaceutical Inc 80,4854.3M $0.84 %
Viking Therapeutics Inc 135,7574.2M $0.82 %
Vertex Pharmaceuticals Inc 9,8604.2M $0.81 %
ImmunityBio Inc 587,0414.2M $0.80 %
Immunovant Inc 147,0474M $0.77 %
Moderna Inc 86,7414M $0.77 %
Vera Therapeutics Inc 109,5573.9M $0.75 %
Immunome Inc 168,1453.9M $0.74 %
Disc Medicine Inc 57,9783.8M $0.74 %
Veracyte Inc 112,1713.7M $0.71 %
Sarepta Therapeutics Inc 175,1213.7M $0.70 %
Catalyst Pharmaceuticals Inc 129,9493.7M $0.70 %
BioCryst Pharmaceuticals Inc 381,3053.5M $0.67 %
Dyne Therapeutics Inc 196,9413.5M $0.67 %
Kodiak Sciences Inc 76,9623.3M $0.64 %
Recursion Pharmaceuticals Inc 958,5743.3M $0.64 %
GRAIL Inc 59,6513.2M $0.63 %
Arcus Biosciences Inc 123,9263.2M $0.61 %
Agios Pharmaceuticals Inc 110,5853.1M $0.60 %
Denali Therapeutics Inc 162,1913M $0.59 %
Oruka Therapeutics Inc 43,5763M $0.57 %
Dianthus Therapeutics Inc 33,6053M $0.57 %
Intellia Therapeutics Inc 215,0072.9M $0.56 %
Erasca Inc 271,1942.9M $0.56 %
ADMA Biologics Inc 281,6742.9M $0.56 %
Syndax Pharmaceuticals Inc 134,2422.9M $0.55 %
Ardelyx Inc 438,9912.8M $0.54 %
Ideaya Biosciences Inc 93,3002.7M $0.52 %
Mineralys Therapeutics Inc 101,5562.7M $0.52 %
Nurix Therapeutics Inc 160,9372.7M $0.52 %
Tango Therapeutics Inc 112,9752.4M $0.47 %
Celldex Therapeutics Inc 70,0172.3M $0.44 %
Capricor Therapeutics Inc 67,1082.3M $0.43 %
Vericel Corp 63,9312.2M $0.43 %
Inhibrx Biosciences Inc 16,9612.2M $0.42 %
Monte Rosa Therapeutics Inc 112,6092.2M $0.42 %
Novavax Inc 267,3792.1M $0.41 %
Biohaven Ltd 220,1602.1M $0.41 %
Stoke Therapeutics Inc 64,4712.1M $0.41 %
Relay Therapeutics Inc 162,1162.1M $0.40 %
Taysha Gene Therapies Inc 322,7912.1M $0.40 %
Viridian Therapeutics Inc 152,8152.1M $0.40 %
Olema Pharmaceuticals Inc 141,5582M $0.39 %
Palvella Therapeutics Inc 15,7052M $0.39 %
uniQure NV 97,1631.9M $0.37 %
AnaptysBio Inc 29,3281.9M $0.37 %
Corvus Pharmaceuticals Inc 121,2011.8M $0.35 %
MannKind Corp 625,9211.8M $0.34 %
CareDx Inc 84,7421.8M $0.34 %
KalVista Pharmaceuticals Inc 61,6711.6M $0.32 %
Iovance Biotherapeutics Inc 466,0511.6M $0.30 %
Vir Biotechnology Inc 144,6751.5M $0.28 %
Geron Corp 951,0401.5M $0.28 %